The UK Medicines Agency has given the green light for Moderna’s Corona vaccine adapted to the omicron variant. A clinical study has shown that the vaccine elicits a “strong immune response” against both the parent virus strain and the omicron variant. The test is still ongoing in the EU.
The MHRA announced Monday that the US biotechnology company’s vaccine had been approved for adult stimulation.
It is the first so-called bivalent corona vaccine to be approved in Great Britain. The vaccines available so far have helped reduce the number of corona-related hospitalizations and deaths. However, they mainly focus on earlier strains of the coronavirus.
“Good” results achieved
The Moderna vaccine, called Spikevax bivalent Original/Omicron, targets both the original strain of the coronavirus, which first appeared in 2020, and the Omicron variant BA.1. “Good” results were also obtained for the subtypes BA.4 and BA.5 of the omicron variant.
The modified Moderna vaccine is also currently under investigation by the EU medicines agency EMA. At the same time, the EMA is investigating a modified vaccine from Biontech/Pfizer (see video above). Its approval is planned for the fall.
Source: Krone
I’m Wayne Wickman, a professional journalist and author for Today Times Live. My specialty is covering global news and current events, offering readers a unique perspective on the world’s most pressing issues. I’m passionate about storytelling and helping people stay informed on the goings-on of our planet.
